Adacel®

ADACEL® IS BOOSTER VACCINE THAT HELPS PROTECT AGAINST TETANUS, DIPHTHERIA, PERTUSSIS AND POLIO.
With reduced quantities of diphtheria and pertussis antigens, ADACEL® has been specifically formulated for boosting immunization in adolescents and adults. ADACEL® is ready-to-use vaccine.

Amaryl®

Glimepiride is an orally active hypoglycaemic substance belonging to the sulfonylurea group. It may be used in non-insulin dependent diabetes mellitus.

Apidra®

Insulin Glulisine, a fast-acting insulin administered subcutaneously used for treatment of adults, adolescents and children 6 years or older, with diabetes mellitus, where treatment with insulin is required.

Aprovel®

Irbesartan is a potent, orally active, selective angiotensin-II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin-II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin-II used to Effectively control Hypertension to normal Rates.

Aubagio®

AUBAGIO® is a once-daily oral tablet that is indicated for adult patients with relapsing remitting multiple sclerosis (RRMS)
   

Clexane®

Enoxaparin Sodium is a low molecular weight heparin (LMWH) that is administered subcutaneously and used as antithrombotic agent.

Dupixent®

Is a fully human monoclonal antibody with multiple indications in different therapeutic areas.


 

Lantus®

Insulin Glargine 100, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 2 years.

Lemtrada®

Lemtrada® is a monoclonal antibody produced in mammalian cells (Chinese Hamster Ovary).

Myozyme®

Pompe disease product information.

Plavix®

Clopidogrel is an inhibitor of platelet aggregation administered orally and indicated for Secondary prevention of atherothrombotic events.
 

Praluent®

Alirocumab is a fully human IgG1 monoclonal antibody. It’s a PCSK9 inhibitor that is administered subcutaneously.
 

Renvela®

Sevelamer Carbonate is indicated for the control of hyperphosphatemia in adult patients receiving haemodialysis or peritoneal dialysis. The recommended starting dose of sevelamer carbonate is 2.4 g or 4.8 g per day and must be taken 3 times per day with meals.  

Sarclisa®

Isatuximab is an immunoglobulin G1 (IgG1) monoclonal antibody (mAb) for the treatment of adult patients with relapsed and refractory multiple myeloma in combined regimens.

Solian®

Amisulpride is a once-daily dose used for the treatment on schizophrenia if the dose is less than 400mg and twice-daily if the dose exceeds 400mg

Soliqua®

Combination of Insulin Glargine (a basal insulin analog) & Lixisenatide (a GLP-1 receptor agonist) administered subcutaneously.
 

Tavanic®

Levofloxacin is used in adults for the treatment of infections. The dosage depends on the type and severity of the infection and the susceptibility of the presumed causative pathogen.

Toujeo®

Insulin Glargine 300, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 6 years.

Xatral®

Alfuzosin is a once-daily dose used in the treatment of the functional symptoms of benign prostatic hypertrophy.

Xenpozyme®

Xenpozyme is FIRST AND ONLY APPROVED TREATMENT THAT ADDRESSES THE UNDERLYING CAUSE OF NON-CNS MANIFESTATIONS OF ASMD TYPE A/B OR TYPE B AND CAN HELP REVERSE DISEASE PROGRESSION IN PEDIATRIC AND ADULT PATIENTS.

Zympass®

Combination of Rosuvastatin Calcium & Ezetimibe used as adjunct to diet for treatment of Primary Hypercholesterolemia or Homozygous Familial Hypercholesterolemia.

▼ This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.